Response of myasthenia gravis to rituxim
โ
Ajeet Gajra; Neerja Vajpayee; Sara J. Grethlein
๐
Article
๐
2004
๐
John Wiley and Sons
๐
English
โ 43 KB
๐ 2 views
## Abstract Myasthenia gravis is a Bโcellโmediated autoimmune neuromuscular disorder characterized by weakness and fatigability of skeletal muscles. The underlying defect is an autoantibodyโmediated attack on the acetylcholine receptors (AchRs) at the neuromuscular junction. Rituximab is a genetica